AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.

Donald Trump's administration introduced an AI Action Plan. The plan focuses on reducing regulations and boosting technology ...

Investors are so bullish that Palantir stock recently zoomed past $150 per share, giving it a market cap of nearly $350 ...

C3.ai's strong growth in the AI software market could be undervalued. Shares of Marvell Technology are trading at a cheap ...

BigBear.ai BBAI is accelerating its global expansion strategy with a focus on turning promising international pilots into sustainable revenue generators. In first-quarter 2025, the company partnered ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

The administration’s long-awaited AI Action Plan gives Silicon Valley the green light.

Knightscope, Inc., a pioneer in developing autonomous security robots and artificial intelligence technologies, announced it ...

America’s AI Action Plan,” unveiled at a Hill & Valley conference, outlined three pillars to secure US dominance in the ...

The US has recently reversed a ban on Nvidia that restricted them from sending its export control-compliant chip known as the ...

L3Harris gains margin strength and AI-driven growth through its Shield AI partnership, with 18% upside and long-term ...

There are three names attached to the Trump administration’s newly published AI Action Plan. One is the US Secretary of State ...